Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Endocrinology

• Publication date

  2014-03-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2013-1447PMID 24601880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats[S]

  2013cited by this paper
• Possible mechanisms of circulating PYY-induced satiation in male rats.

  2013cited by this paper
• Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

  2012cited by this paper
• Current evidence for a role of GLP‐1 in Roux‐en‐Y gastric bypass‐induced remission of type 2 diabetes

  2012cited by this paper
• Inconsistencies in the assessment of food intake.

  2012cited by this paper
• Vagal Afferents Mediate Early Satiation and Prevent Flavour Avoidance Learning in Response to Intraperitoneally Infused Exendin‐4

  2012cited by this paper
• Integrative and Translational Physiology : Integrative Aspects of Energy Homeostasis and Metabolic Diseases Meal-contingent intestinal lymph sampling from awake , unrestrained rats

  2012cited by this paper
• Obesity – an indication for GLP‐1 treatment? Obesity pathophysiology and GLP‐1 treatment potential

  2011cited by this paper
• Glucagon-like peptide 1 and the brain: central actions-central sources?

  2011cited by this paper
• Effects of Exendin‐4 Alone and With Peptide YY3–36 on Food Intake and Body Weight in Diet‐Induced Obese Rats

  2011cited by this paper
• Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications.

  2011cited by this paper
• The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.

  2011cited by this paper
• Effects of anesthesia and blood sampling techniques on plasma metabolites and corticosterone in the rat.

  2010cited by this paper
• Hepatic‐Portal Vein Infusions of Glucagon‐Like Peptide‐1 Reduce Meal Size and Increase c‐Fos Expression in the Nucleus Tractus Solitarii, Area Postrema and Central Nucleus of the Amygdala in Rats

  2010cited by this paper
• Exenatide and weight loss.

  2010cited by this paper
• Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects.

  2010cited by this paper
• Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist.

  2010cited by this paper
• Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.

  2009cited by this paper
• Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats

  2009cited by this paper
• Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.

  2009cited by this paper
• Stimulation of incretin secretion by dietary lipid: is it dose dependent?

  2009cited by this paper
• Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.

  2009cited by this paper
• Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake

  2008cited by this paper
• Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation.

  2008cited by this paper
• The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size.

  2007cited by this paper
• Biology of incretins: GLP-1 and GIP.

  2007cited by this paper
• Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei.

  2007influential reference
• The physiology of glucagon-like peptide 1.

  2007cited by this paper
• Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system.

  2007cited by this paper
• Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?

  2006cited by this paper
• What do we know about the secretion and degradation of incretin hormones?

  2005cited by this paper
• Glucagon-like peptide 1 (GLP-1) and eating.

  2004cited by this paper
• Circulation and Degradation of GIP and GLP-1

  2004cited by this paper
• Enhancement of feeding suppression by PYY(3-36) in rats with area postrema ablations.

  2004cited by this paper
• Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change.

  2003cited by this paper
• Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites

  2003influential reference
• Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.

  2003cited by this paper
• The Diverse Roles of Specific GLP-1 Receptors in the Control of Food Intake and the Response to Visceral Illness

  2002cited by this paper
• Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.

  2002cited by this paper
• University of Groningen Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats

  2002cited by this paper
• Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

  2001cited by this paper
• Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.

  2001cited by this paper
• Prandial lactate infusion inhibits spontaneous feeding in rats.

  2000cited by this paper
• The Role of CNS Glucagon-Like Peptide-1 (7-36) Amide Receptors in Mediating the Visceral Illness Effects of Lithium Chloride

  2000cited by this paper
• Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat

  1999cited by this paper
• A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.

  1999cited by this paper
• Glucagon-like peptide-1: a potent regulator of food intake in humans

  1999cited by this paper
• Oral triacylglycerols regulate plasma glucagon-like peptide-1(7-36) and insulin levels in normal and especially in obese rats.

  1999cited by this paper
• Impaired osmoregulatory responses in rats with area postrema lesions.

  1999cited by this paper
• In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera.

  1999influential reference
• Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress.

  1999cited by this paper
• Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system

  1999cited by this paper
• Lipopolysaccharide-induced anorexia following hepatic portal vein and vena cava administration.

  1998cited by this paper
• Conditioned Flavor Preferences: Evaluating Postingestive Reinforcement by Nutrients

  1998cited by this paper
• PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats.

  1998cited by this paper
• Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

  1997cited by this paper
• Glucagon-Like Peptide I Receptors in the Subfornical Organ and the Area Postrema Are Accessible to Circulating Glucagon-Like Peptide I

  1996cited by this paper
• Hepatic portal insulin antibody infusion increases, but insulin does not alter, spontaneous meal size in rats.

  1995cited by this paper
• Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

  1995cited by this paper
• Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.

  1995cited by this paper
• Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites

  1995cited by this paper
• Lithium chloride-induced anorexia, but not conditioned taste aversions, in rats with area postrema lesions.

  1994cited by this paper
• The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.

  1994cited by this paper
• Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.

  1993cited by this paper
• Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

  1993cited by this paper
• Fourth ventricular phlorizin dissociates feeding from hyperglycemia in rats.

  1985cited by this paper
• The central neural connections of the area postrema of the rat

  1985cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Glucoreceptors controlling feeding and blood glucose: location in the hindbrain.

  1981cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979influential reference

• Liraglutide Induces Enhanced Suppression of Food Intake in Mice Lacking the Growth Hormone Secretagogue Receptor.

  2025cites this paper
• Gut–Brain Axis and Bile Acid Signaling: Linking Microbial Metabolism to Brain Function and Metabolic Regulation

  2025cites this paper
• GLP-1 and the Neurobiology of Eating Control: Recent Advances

  2025cites this paper
• Impacts of different pancreatic resection ranges on endocrine function in Suncus murinus

  2024cites this paper
• Brain access of incretins and incretin receptor agonists to their central targets relevant for appetite suppression and weight loss

  2024cites this paper
• The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases

  2024cites this paper
• Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart

  2024influential citation
• GLP-1R–positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice

  2024cites this paper
• Neurochemical Basis of Inter-Organ Crosstalk in Health and Obesity: Focus on the Hypothalamus and the Brainstem

  2023cites this paper
• Roles of bile acids signaling in neuromodulation under physiological and pathological conditions

  2023cites this paper
• “To brain or not to brain”: evaluating the possible direct effects of the satiety factor oleoylethanolamide in the central nervous system

  2023cites this paper
• Macronutrient intake: Hormonal controls, pathological states, and methodological considerations.

  2022cites this paper
• Post-oral fat-induced satiation is mediated by endogenous CCK and GLP-1 in a fat self-administration mouse model.

  2021cites this paper
• Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective

  2021cites this paper
• Central and peripheral GLP-1 systems independently suppress eating

  2021cites this paper
• Vagal afferent cholecystokinin receptor activation is required for glucagon‐like peptide‐1–induced satiation

  2021cites this paper
• The Physiological Control of Eating: Signals, Neurons, and Networks.

  2021cites this paper
• Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment

  2021cites this paper
• Mind affects matter: Hindbrain GLP1 neurons link stress, physiology and behaviour

  2021cites this paper
• Reappraising the role of the vagus nerve in GLP‐1‐mediated regulation of eating

  2021cites this paper
• The diverse effects of brain glucagon‐like peptide 1 receptors on ingestive behaviour

  2021cites this paper
• Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake.

  2021cites this paper
• Ghrelin and Glucagon-Like Peptide-1: A Gut-Brain Axis Battle for Food Reward

  2021cites this paper
• Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment.

  2021cites this paper
• Central and peripheral GLP-1 systems independently suppress eating

  2021cites this paper
• Intestinal glucagon-like peptide-1 effects on food intake: physiological relevance and emerging mechanisms.

  2020cites this paper
• GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats

  2020cites this paper
• A role for GLP-1 in treating hyperphagia and obesity.

  2020cites this paper
• Central and peripheral GLP-1 systems independently and additively suppress eating

  2020cites this paper
• Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress

  2020cites this paper
• Serendipity and spontaneity - Critical components in 40 years of academia.

  2019cites this paper
• Glucagon-like peptide 1 (GLP-1)

  2019influential citation
• Endocrine Control of Food Intake

  2019cites this paper
• A Rat Model of Human Lipid Emulsion Digestion

  2019cites this paper
• The Iminosugar AMP-DNM Improves Satiety and Activates Brown Adipose Tissue Through GLP1

  2019cites this paper
• Glucagon, GLP-1 and Thermogenesis

  2019cites this paper
• Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors on A

  2018cites this paper
• Brainstem GLP‐1 signalling contributes to cancer anorexia‐cachexia syndrome in the rat

  2018cites this paper
• Neuroendocrinology of Energy Balance

  2018cites this paper
• Oleoylethanolamide‐induced anorexia in rats is associated with locomotor impairment

  2018cites this paper
• The role of the vagus nerve in appetite control: Implications for the pathogenesis of obesity

  2018cites this paper
• Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk factors: A narrative review of head‐to‐head comparisons

  2017cites this paper
• Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System

  2017cites this paper
• Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

  2017cites this paper
• Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors Dalsgaard,

  2017cites this paper
• Intestinal GLP-1 and satiation: from man to rodents and back

  2016cites this paper
• Metabolism and Mental Illness.

  2016cites this paper
• Afferent Endocrine Control of Eating

  2016cites this paper
• Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.

  2016cites this paper
• Effects of solid‐phase extraction of plasma in measuring gut metabolic hormones in fasted and fed blood of lean and diet‐induced obese rats

  2016cites this paper
• Vagal mediation of GLP-1's effects on food intake and glycemia.

  2015cites this paper
• Gastroduodenal mucosal defense mechanisms

  2015cites this paper
• Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling.

  2015cites this paper
• PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.

  2015cites this paper
• Parabrachial Nucleus Contributions to Glucagon-Like Peptide-1 Receptor Agonist-Induced Hypophagia

  2015cites this paper
• Does the glucagon-like peptide-1 act through the vagal afferent neurons to modulate anxiety, food neophobia and food reward behaviour?

  2015cites this paper
• Glucagon-Like Peptide 1 Interacts with Ghrelin and Leptin to Regulate Glucose Metabolism and Food Intake through Vagal Afferent

  2015cites this paper
• Instructions for Annotating Your . PDF Proof

  2014cites this paper
• GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatment

  2014cites this paper
• Enterocyte–afferent nerve interactions in dietary fat sensing

  2014cites this paper
• World Journal of Gastrointestinal Surgery

  year unknowncites this paper